Browse > Article

Effects of Hwanggeum-tang Aqueous Extracts on Streptozotocin-induced Rat's Diabetes and Related Complications  

Choi, Byeong-Heon (Department of Oriental Internal Medicine, College of Oriental Medicine, Daegu Haany University)
Yoon, Gyeong-Min (Department of Oriental Internal Medicine, College of Oriental Medicine, Daegu Haany University)
Kang, Seok-Bong (Department of Oriental Internal Medicine, College of Oriental Medicine, Daegu Haany University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.25, no.4, 2011 , pp. 683-690 More about this Journal
Abstract
The object of this study was to observe the effects of Hwanggeum-tang (HGT) aqueous extracts on Streptozotocin-induced rat's diabetes and related complications. Three different dosages of HGT extracts were orally administered oncea day for 28 days from 3 weeks after Streptozotocin treatment (60 mg/kg, single intraperitoneally administered). All the rats were checked at 3 weeks after Streptozotocin treatment as follows. Changes on the body weight, blood glucose level, kidney weight, serum BUN and creatinine level, liver weight, serum AST and ALT level, serum LDL, HDL, triglyceride and total cholesterol level were observed with changes on the pancreatic MDA content and GSH content. The results were compared with a potent antioxidant silymarin 100 mg/kg in which the effects on Streptozotocin-induced diabetes and related complications were already confirmed. As results of Streptozotocin-injected diabetes and related complications, dramatical decreases on the body weight, increase of the kidney and liver weight, increase of serum BUN, creatinine, AST, ALT, LDL, triglyceride, total cholesterol level and decreases of serum HDL level were detected in streptozotocin control as compared with intact control. In addition, marked increases of pancreatic MDA content and decreases of GSH content were also detected in streptozotocin control as compared with intact control. However, these diabetes and related complications, and inhibition of antioxidant effects induced by Streptozotocin were inhibited by 28 days continuous treatment of 50, 100 and 200 mg/kg of HGT extracts in the present study. HGT have favorable effects on the diabetes and various diabetic complications. Therefore, more detail mechanism studies should be conducedin future with the efficacy tests of individual herbal composition of HGT and the screening of the biological active compounds in herbs.
Keywords
Hwanggeum-tang(Huangqin-shang); diabetes; hyperlipemia; antioxidant; silymarin;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Clark, T.A., Heyliger, C.E., Edel, A.L., Goel, D.P., Pierce, G.N. Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in streptozotocin-induced diabetic rats. Metabolism. 53: 1145-1151, 2004.   DOI   ScienceOn
2 Yanardag, R., Ozsoy-Sacan, O., Bolkent, S., Orak, H., Karabulut-Bulan, O. Protective effects of metformin treatment on the liver injury of streptozotocin-diabetic rats. Hum Exp Toxicol. 24: 129-135, 2005.   DOI   ScienceOn
3 Ducobu, J. Dyslipidaemia and diabetes mellitus. Rev Med Liege. 60: 578-585, 2005.
4 Bhandari, U., Kanojia, R., Pillai, K.K. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol. 97: 227-230, 2005.   DOI   ScienceOn
5 Garg, M.C., Singh, K.P., Bansal, D.D.. Effect of vitamin C supplementation on oxidative stress in experimental diabetes. Indian J Exp Biol. 35: 264-266, 1997.
6 Collier, A., Wilson, R., Bradley, H., Thomson, J.A., Small, M. Free radical activity in type 2 diabetes. Diabet Med. 7: 27-30, 1990.   DOI   ScienceOn
7 Ceriello, A., Quatraro, A., Giugliano, D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med. 9: 297-299, 1992.   DOI   ScienceOn
8 Giugliano, D., Ceriello, A., Paolisso, G. Oxidative stress and diabetic vascular complications. Diabetes Care. 19: 257-267, 1996.   DOI   ScienceOn
9 Lirussi, F., Beccarello, A., Zanette, G., De Monte, A., Donadon, V., Velussi, M., Crepaldi, G. Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent. Diabetes Nutr Metab. 15: 222-231, 2002.
10 Huseini, H.F., Larijani, B., Heshmat, R., Fakhrzadeh, H., Radjabipour, B., Toliat, T., Raza, M. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 20: 1036-1039, 2006.   DOI   ScienceOn
11 鞠潤範, 金相贊, 朴宣東, 朴性奎, 徐富一, 徐榮培, 申舜植, 李尙仁, 李長泉, 李棣, 鄭宗佶, 朱榮丞, 崔湖榮. 方劑學. 서울, 圖書出版 永林社, pp 205-206, 2008.
12 Guerrero-Analco, J.A., Hersch-Martinez, P., Pedraza-Chaverri, J., Navarrete, A., Mata, R. Antihyperglycemic effect of constituents from Hintonia standleyana in streptozotocin-induced diabetic rats. Planta Med. 71: 1099-1105, 2005.   DOI   ScienceOn
13 Pinzone Fox, M.L., Sastry, M.K., Parenti, D.M., Simon, G.L. : Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight. J Endocrinol Invest. 28: 1-3, 2005.   DOI
14 Cohen, M.P., Clements, R.S., Cohen, J.A., Shearman, C.W. Prevention of decline in renal function in the diabetic db/db mouse. Diabetologia. 39: 270-274, 1996.   DOI   ScienceOn
15 Trachtman, H., Futterweit, S., Pine, E., Mann, J., Valderrama, E. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol. 17: 20-29, 2002.   DOI   ScienceOn
16 Montilla, P., Barcos, M., Munoz, M.C., Bujalance, I., Munoz-Castaneda, J.R., Tunez, I. Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats. J Biochem Mol Biol. 38: 539-544, 2005.   DOI
17 Sato, S., Yamate, J., Hori, Y., Hatai, A., Nozawa, M., Sagai, M. Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats. J Nutr Biochem. 16: 547-553, 2005.   DOI   ScienceOn
18 Sodikoff, C.H. Laboratory profiles of small animal diseases. : A guide to laboratory diagnosis. 2nd ed., St. Louise: Mosby. pp 1-36, 1995.
19 Imaeda, A., Kaneko, T., Aoki, T., Kondo, Y., Nakamura, N., Nagase, H., Yoshikawa, T. Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice. Food Chem Toxicol. 40: 1415-1422, 2002.   DOI   ScienceOn
20 龔 靂. (對譯)萬病回春. 서울, 法仁文化社, p 32, 2007.
21 Kavutcu, M., Canbolat, O., Oztürk, S., Olcay, E., Ulutepe, S., Ekinci, C., GOkhun, I.H., Durak, I. Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: effects of vitamins E and C. Nephron. 72: 269-274, 1996.   DOI
22 許 浚. (對譯)東醫寶鑑. 서울, 法仁文化社, p 1332, 1999.
23 杜鎬京. 東醫腎系學. 서울, 성보사, pp 1139-1140, 2003.
24 nstitute of Laboratory Animal Resources(Commission on Life Sciences, National Research Council, USA). : Guide for the care and use of laboratory animals. Washington, D.C. : National Academic press. pp 1-118, 1996.
25 Lowry, O.H., Rosenbrough, N.J., Farr, A.L., Randall, R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193: 265-275, 1951.
26 Draper, H.H., Hadley, M. Methods in Enzymology. New York: Academic Press. p 421, 1990.
27 Eyer, P., Podhradský, D. Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent. Anal Biochem. 153: 57-66, 1986.   DOI   ScienceOn
28 Sathishsekar, D., Subramanian, S. Beneficial effects of Momordica charantia seeds in the treatment of streptozotocin-induced diabetes in experimental rats. Biol Pharm Bull. 28: 978-983, 2005.   DOI   ScienceOn
29 Quine, S.D., Raghu, P.S. Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in streptozotocin-induced diabetic liver, kidney and heart. Pharmacol Rep. 57: 610-615, 2005.
30 Wellington, K., Jarvis, B. Silymarin: a review of its clinical properties in the management of hepatic disorders. Bio Drugs. 15: 465-489, 2001.
31 Lorenz, D., Mennicke, W.H. Elimination of drugs in cholecystectomized patients. Studies with silymarin in patients with extrahepatic complications. Methods Find Exp Clin Pharmacol. 3: 103-106, 1981.
32 Velussi, M., Cernigoi, A.M., De Monte, A., Dapas, F., Caffau, C., Zilli, M. Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol. 26: 871-879, 1997.   DOI   ScienceOn
33 Marx, J. Unravelling the causes of diabetes. Science. 296: 686-689, 2002.   DOI
34 Saller, R., Meier, R., Brignoli, R. The use of silymarin in the treatment of liver diseases. Drugs. 61: 2035-2063, 2001.   DOI   ScienceOn
35 서울대학교의과대학. 내분비학. 서울, 서울대학교출판부, pp 203-204, 2005.
36 대한당뇨병학회. 당뇨병학(제 3판). 서울, 고려의학, pp 1-5, 2005.
37 Tiwari, A.K., Madhusudana Rao, J. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Current Science. 83: 30-38, 2002.
38 Ojewole, J.A., Adewunmi, C.O. Hypoglycemic effect of methanolic extract of Musa paradisiaca (Musaceae) green fruits in normal and diabetic mice. Methods Find Exp Clin Pharmacol. 25: 453-456, 2003.   DOI   ScienceOn
39 Ivorra, M.D., Paya, M., Villar, A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol. 27: 243-275, 1989.   DOI   ScienceOn
40 Latha, M., Pari, L. Effect of an aqueous extract of Scoparia dulcis on blood glucose, plasma insulin and some polyol pathway enzymes in experimental rat diabetes. Braz J Med Biol Res. 37: 577-586, 2004.   DOI